Research Peptides: Guides & Analysis
Research peptides are short chains of amino acids supplied for in vitro and laboratory research only, not for human or veterinary use. This hub collects our compound guides, side-by-side comparisons and research analysis.
Evidence-based research guides, scientific articles, and educational resources on BPC-157, Semaglutide, Retatrutide, metabolic research, tissue repair and more. Updated regularly for laboratory and independent research.
Copper Peptides Skincare: What Dermatologists Say on GHK-Cu
Copper peptides skincare research centers on GHK-Cu: fibroblast and wound-model data support collagen effects, but human evidence remains small and unblinded.
Brenipatide (LY3537031): Dual GIP/GLP-1 Research Guide
Brenipatide (LY3537031) is Eli Lilly's long-acting dual GIP/GLP-1 receptor agonist being studied in Phase 3 trials for alcohol use disorder and major depressive disorder (NCT07219966, NCT07412756).
Thymosin Alpha-1 Research 2026: Immunity Peptide Study Guide
Thymosin Alpha-1 research covers a 28-amino acid immunomodulatory peptide with documented T-cell activation properties. This guide reviews mechanisms, FDA compounding context, and study parameters for 2026.
Semaglutide vs Tirzepatide Discontinuation Research: Comparative Rebound Data 2026
Semaglutide vs tirzepatide discontinuation research reveals distinct rebound patterns, persistence rates, and reinitiation behaviors. 2025-2026 studies compare weight regain, metabolic reversal, and implications for high-purity research peptide protocols.
CagriSema vs Retatrutide: ADA 2026 Clinical Comparison Research
CagriSema retatrutide comparison reveals two distinct dual-agonist mechanisms targeting obesity. This guide covers receptor profiles, trial data, and research applications for 2026.
Epitalon & Semax: Preclinical Neuroprotective Peptide Studies
Epitalon and Semax neuroprotective peptides show distinct bioregulatory mechanisms in preclinical models. This guide reviews published research on telomerase activation, BDNF upregulation, and receptor binding kinetics.
GLP-1 Cancer Research 2026: Breast & Prostate Tumor Slowdown Studies
GLP-1 cancer research in 2026 reveals that receptor agonists may slow tumor proliferation in breast and prostate models. This guide reviews the mechanisms, study data, and research implications.
Selank Research Peptide: Anxiolytic Mechanism & Lab Protocols 2026
Selank research peptide is a synthetic anxiolytic analog of Tuftsin that upregulates BDNF and modulates GABAergic transmission. This 2026 guide details molecular targets, intranasal dosing protocols, and lab-grade purity requirements for in-vitro and animal studies.
AI Peptide Antibiotic Optimization: 2026 Research Protocols & Data
AI peptide antibiotic optimization is reshaping 2026 antimicrobial research. Discover machine-learning peptide design, lab-validated assays, and sourcing standards for high-purity research peptides.
Novo Nordisk Triple Agonist Obesity Peptide: GGG Tri-Agonist
Triple agonist obesity peptide research targets GIP, GLP-1, and glucagon receptors simultaneously. This guide covers mechanisms, study data, and sourcing standards for researchers.
A Comprehensive Research Guide: Getting Started with Peptides
Discover the essentials of peptide research, including types, applications, quality assurance, and purity testing methods for reliable and reproducible results.